Status:
TERMINATED
A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine what effects Esomeprazole (Nexium) has on increasing or decreasing the amount of oral taxane in the blood, and to determine the safety of oral taxane and effe...
Eligibility Criteria
Inclusion
- Advanced cancers excluding cancers within the blood
- Adequate kidney and liver function
- \> = 4 weeks from last course of chemotherapy
Exclusion
- Inability to swallow capsules
- Other active medical disorder
- Abnormal heart function or use of drugs that affect the heart
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00332748
Start Date
December 1 2006
Last Update
March 2 2010
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Newark, Delaware, United States
2
Local Institution
Louisville, Kentucky, United States
3
Local Institution
Las Vegas, Nevada, United States
4
Local Institution
Amsterdam, Netherlands